One is a drug used to treat rheumatoid arthritis while the other is a monoclonal antibody therapy created to tackle the novel coronavirus. It had said then that it had received permission for restricted emergency use from Central Drugs Standard Control Organisation “for baricitinib in combination with remdesivir, for treatment of suspected or laboratory confirmed Covid-19 in hospitalised adults requiring …
The World Health Organization approved two new Covid-19 treatments on Friday, growing the arsenal of tools along with vaccines to stave off severe illness and death from the virus. In their recommendation in British medical journal the BMJ, WHO experts said arthritis drug baricitinib used with corticosteroids to treat severe or critical Covid patients led to better survival rates and …
